Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Deepak Kilari MD

Deepak Kilari MD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Member of the Cancer Center

Publications (41)

  • Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer. (Huang J, Du M, Soupir A, Wang L, Tan W, Kalari KR, Kilari D, Park J, Huang CC, Kohli M, Wang L) Cancers (Basel) 2022 Sep 28;14(19) PMID: 36230636 PMCID: PMC9562906 SCOPUS ID: 2-s2.0-85139907579 10/15/2022    
  • Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses. (Mehra N, Fizazi K, de Bono JS, Barthélémy P, Dorff T, Stirling A, Machiels JP, Bimbatti D, Kilari D, Dumez H, Buttigliero C, van Oort IM, Castro E, Chen HC, Di Santo N, DeAnnuntis L, Healy CG, Scagliotti GV) Oncologist 2022 Oct 01;27(10):e783-e795 PMID: 36124924 PMCID: PMC9526483 SCOPUS ID: 2-s2.0-85139536391 09/21/2022       1 Citation
  • Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. (Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B, ARASENS Trial Investigators) N Engl J Med 2022 Mar 24;386(12):1132-1142 PMID: 35179323 SCOPUS ID: 2-s2.0-85127335942 02/19/2022       80 Citations
  • Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study. (Koshkin VS, Henderson N, James M, Natesan D, Freeman D, Nizam A, Su CT, Khaki AR, Osterman CK, Glover MJ, Chiang R, Makrakis D, Talukder R, Lemke E, Olsen TA, Jain J, Jang A, Ali A, Jindal T, Chou J, Friedlander TW, Hoimes C, Basu A, Zakharia Y, Barata PC, Bilen MA, Emamekhoo H, Davis NB, Shah SA, Milowsky MI, Gupta S, Campbell MT, Grivas P, Sonpavde GP, Kilari D, Alva AS) Cancer 2022 Mar 15;128(6):1194-1205 PMID: 34882781 SCOPUS ID: 2-s2.0-85120821529 12/10/2021       5 Citations
  • Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development? (Beinhoff P, Sabharwal L, Udhane V, Maranto C, LaViolette PS, Jacobsohn KM, Tsai S, Iczkowski KA, Wang L, Hall WA, Dehm SM, Kilari D, Nevalainen MT) Cancers (Basel) 2021 Oct 17;13(20) PMID: 34680353 PMCID: PMC8533841 SCOPUS ID: 2-s2.0-85117018634 10/24/2021       2 Citations
  • PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer. (Koshkin VS, Patel VG, Ali A, Bilen MA, Ravindranathan D, Park JJ, Kellezi O, Cieslik M, Shaya J, Cabal A, Brown L, Labriola M, Graham LS, Pritchard C, Tripathi A, Nusrat S, Barata P, Jang A, Chen SR, Garje R, Acharya L, Hwang C, Pilling A, Oh W, Jun T, Natesan D, Nguyen C, Kilari D, Pierro M, Thapa B, Cackowski F, Mack A, Heath E, Marshall CH, Tagawa ST, Halabi S, Schweizer MT, Armstrong A, Dorff T, Alva A, McKay R) Prostate Cancer Prostatic Dis 2022 Sep;25(3):388-396 PMID: 34363009 PMCID: PMC9385488 SCOPUS ID: 2-s2.0-85112618674 08/08/2021       6 Citations
  • Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial. (Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF) Pract Radiat Oncol 2021;11(6):527-533 PMID: 33848618 PMCID: PMC8638529 SCOPUS ID: 2-s2.0-85107984420 04/14/2021       1 Citation
  • Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort. (Barata P, Hatton W, Desai A, Koshkin V, Jaeger E, Manogue C, Cotogno P, Light M, Lewis B, Layton J, Sartor O, Basu A, Kilari D, Emamekhoo H, Bilen MA) Front Oncol 2020;10:581189 PMID: 33194712 PMCID: PMC7642690 SCOPUS ID: 2-s2.0-85095695510 11/17/2020       8 Citations
  • Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort (Barata P, Hatton W, Desai A, Koshkin V, Jaeger E, Manogue C, Cotogno P, Light M, Lewis B, Layton J, Sartor O, Basu A, Kilari D, Emamekhoo H, Bilen MA) Frontiers in Oncology 22 October 2020;10 SCOPUS ID: 2-s2.0-85095695510 10/22/2020       8 Citations
  • Outcomes With Liver-Directed Therapy for Genitourinary Malignancies: Single-Institution Experience. (Pierro M, Raychaudhuri R, Lea WB, Rilling W, Davis N, Bylow K, Kilari D) Clin Genitourin Cancer 2021 Feb;19(1):87-91 PMID: 32778506 SCOPUS ID: 2-s2.0-85089247313 08/12/2020       1 Citation
  • CDK12-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade. (Schweizer MT, Ha G, Gulati R, Brown LC, McKay RR, Dorff T, Hoge ACH, Reichel J, Vats P, Kilari D, Patel V, Oh WK, Chinnaiyan A, Pritchard CC, Armstrong AJ, Montgomery RB, Alva A) JCO Precis Oncol 2020;4:382-392 PMID: 32671317 PMCID: PMC7363399 07/17/2020    
  • Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating Mutation. (Kmak JA, Agarwal N, He Y, Heilmann AM, Miller VA, Ross JS, Pal SK, Ali SM, Kilari D) Case Rep Oncol 2020;13(1):456-461 PMID: 32399016 PMCID: PMC7204854 SCOPUS ID: 2-s2.0-85084410749 05/14/2020    
  • Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer. (Du M, Tian Y, Tan W, Wang L, Wang L, Kilari D, Huang CC, Wang L, Kohli M) Prostate Cancer Prostatic Dis 2020 Dec;23(4):705-713 PMID: 32203070 PMCID: PMC7501185 SCOPUS ID: 2-s2.0-85082799475 03/24/2020       11 Citations
  • Salvage ipilimumab associated with a significant response in sarcomatoid renal cell carcinoma. (George G, Schmidt L, Tolat P, Riese M, Kilari D) J Immunother Cancer 2020 Feb;8(1) PMID: 32114501 PMCID: PMC7057424 SCOPUS ID: 2-s2.0-85080840435 03/03/2020       3 Citations
  • The Role of Metastasectomy in Urothelial Carcinoma: Where Are We in 2020? (Lemke E, Sahasrabudhe D, Guancial E, Bylow K, Johnson S, Messing E, Kilari D) Clin Genitourin Cancer 2020 Aug;18(4):e478-e483 PMID: 32085986 SCOPUS ID: 2-s2.0-85079745146 02/23/2020       1 Citation
  • Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors. (Udhane V, Maranto C, Hoang DT, Gu L, Erickson A, Devi S, Talati PG, Banerjee A, Iczkowski KA, Jacobsohn K, See WA, Mirtti T, Kilari D, Nevalainen MT) Mol Cancer Ther 2020 Jan;19(1):231-246 PMID: 31548294 PMCID: PMC6946850 SCOPUS ID: 2-s2.0-85077669370 09/25/2019       11 Citations
  • Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review. (Borkenhagen JF, Eastwood D, Kilari D, See WA, Van Wickle JD, Lawton CA, Hall WA) J Natl Compr Canc Netw 2019 Jul 01;17(7):829-837 PMID: 31319388 SCOPUS ID: 2-s2.0-85070084884 07/19/2019       5 Citations
  • Palliative care education for oncologists: how are we doing? (Robbins JR, Kilari D, Johnston F) Ann Palliat Med 2019 Sep;8(4):364-371 PMID: 30943741 SCOPUS ID: 2-s2.0-85073085975 04/05/2019       5 Citations
  • Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades. (Kilari D, D'Souza A, Fraser R, Qayed M, Davila O, Agrawal V, Diaz MA, Chhabra S, Cerny J, Copelan E, Farhadfar N, Freytes CO, Gale RP, Ganguly S, Hildebrandt GC, Holmberg L, Kamble RT, Kapoor P, Lazarus H, Lee C, Murthy HS, Naik S, Nishihori T, Saad A, Savani BN, Seo S, Warwick A, Wirk B, Yared JA, Nieto Y, Hari P) Biol Blood Marrow Transplant 2019 Jun;25(6):1099-1106 PMID: 30794931 PMCID: PMC6559839 SCOPUS ID: 2-s2.0-85064954131 02/23/2019       5 Citations
  • CDK12-mutated prostate cancer: Clinical outcomes with standard therapies and immune checkpoint blockade (Schweizer MT, Ha G, Gulati R, Brown LC, McKay RR, Dorff T, Hoge ACH, Reichel J, Vats P, Kilari D, Patel V, Oh WK, Chinnaiyan A, Pritchard CC, Armstrong AJ, Montgomery RB, Alva A) JCO Precision Oncology 2019;3:382-392 SCOPUS ID: 2-s2.0-85086473721 01/01/2019       30 Citations
  • Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients. (Kohli M, Li J, Du M, Hillman DW, Dehm SM, Tan W, Carlson R, Campion MB, Wang L, Wang L, Zhang H, Zhang P, Kilari D, Huang CC, Wang L) Prostate Cancer Prostatic Dis 2018 Sep;21(3):411-418 PMID: 29858592 PMCID: PMC6126974 SCOPUS ID: 2-s2.0-85047928806 06/03/2018       24 Citations
  • Immune Checkpoint Inhibitor-Associated Type 1 Diabetes Mellitus: Case Series, Review of the Literature, and Optimal Management. (Kapke J, Shaheen Z, Kilari D, Knudson P, Wong S) Case Rep Oncol 2017;10(3):897-909 PMID: 29279690 PMCID: PMC5731100 SCOPUS ID: 2-s2.0-85031826225 12/28/2017       38 Citations
  • Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer. (Du M, Giridhar KV, Tian Y, Tschannen MR, Zhu J, Huang CC, Kilari D, Kohli M, Wang L) Oncotarget 2017 Sep 08;8(38):63703-63714 PMID: 28969022 PMCID: PMC5609954 SCOPUS ID: 2-s2.0-85028376284 10/04/2017       36 Citations
  • Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm. (Raychaudhuri R, Riese MJ, Bylow K, Burfeind J, Mackinnon AC, Tolat PP, Iczkowski KA, Kilari D) Clin Genitourin Cancer 2017 Oct;15(5):e897-e901 PMID: 28645484 SCOPUS ID: 2-s2.0-85020921698 06/25/2017       13 Citations
  • Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles. (Hoang DT, Iczkowski KA, Kilari D, See W, Nevalainen MT) Oncotarget 2017 Jan 10;8(2):3724-3745 PMID: 27741508 PMCID: PMC5356914 SCOPUS ID: 2-s2.0-85009775057 10/16/2016       74 Citations
  • Applications of Extracellular RNAs in Oncology. (Thompson JR, Zhu J, Kilari D, Wang L) Mol Diagn Ther 2017 Feb;21(1):1-11 PMID: 27688207 SCOPUS ID: 2-s2.0-84989170631 10/01/2016       2 Citations
  • Case Report: Spironolactone Withdrawal Associated With a Dramatic Response in a Patient With Metastatic Castrate-Resistant Prostate Cancer. (Flynn T, Guancial EA, Kilari M, Kilari D) Clin Genitourin Cancer 2017 Feb;15(1):e95-e97 PMID: 27641657 SCOPUS ID: 2-s2.0-84994708562 09/20/2016       9 Citations
  • Gaps in nutritional research among older adults with cancer. (Presley CJ, Dotan E, Soto-Perez-de-Celis E, Jatoi A, Mohile SG, Won E, Alibhai S, Kilari D, Harrison R, Klepin HD, Wildes TM, Mustian K, Demark-Wahnefried W) J Geriatr Oncol 2016 Jul;7(4):281-92 PMID: 27197919 PMCID: PMC4969118 SCOPUS ID: 2-s2.0-84971324913 05/21/2016       37 Citations
  • Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting. (Kilari D, Soto-Perez-de-Celis E, Mohile SG, Alibhai SM, Presley CJ, Wildes TM, Klepin HD, Demark-Wahnefried W, Jatoi A, Harrison R, Won E, Mustian KM) J Geriatr Oncol 2016 Jul;7(4):293-304 PMID: 27197916 PMCID: PMC4969104 SCOPUS ID: 2-s2.0-84971268860 05/21/2016       46 Citations
  • Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer. (Guancial EA, Kilari D, Xiao GQ, Abu-Farsakh SH, Baran A, Messing EM, Kim ES) PLoS One 2016;11(5):e0155503 PMID: 27187160 PMCID: PMC4871463 SCOPUS ID: 2-s2.0-84969505076 05/18/2016       5 Citations
  • Role of copper transporters in platinum resistance. (Kilari D, Guancial E, Kim ES) World J Clin Oncol 2016 Feb 10;7(1):106-13 PMID: 26862494 PMCID: PMC4734932 SCOPUS ID: 2-s2.0-84956653652 02/11/2016       72 Citations
  • Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients. (Kilari D, Iczkowski KA, Pandya C, Robin AJ, Messing EM, Guancial E, Kim ES) Anticancer Res 2016 Feb;36(2):495-501 PMID: 26851002 SCOPUS ID: 2-s2.0-84962195660 02/07/2016       33 Citations
  • Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer. (Xia S, Kohli M, Du M, Dittmar RL, Lee A, Nandy D, Yuan T, Guo Y, Wang Y, Tschannen MR, Worthey E, Jacob H, See W, Kilari D, Wang X, Hovey RL, Huang CC, Wang L) Oncotarget 2015 Jun 30;6(18):16411-21 PMID: 25915538 PMCID: PMC4599278 SCOPUS ID: 2-s2.0-84937898954 04/29/2015       37 Citations
  • How we treat early systemic prostate cancer in older men. (Kilari D, Dale W, Mohile SG) J Geriatr Oncol 2014 Oct 01;5(4):337-42 PMID: 25248671 SCOPUS ID: 2-s2.0-84908256130 09/25/2014       6 Citations
  • Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer. (Kim ES, Tang X, Peterson DR, Kilari D, Chow CW, Fujimoto J, Kalhor N, Swisher SG, Stewart DJ, Wistuba II, Siddik ZH) Lung Cancer 2014 Jul;85(1):88-93 PMID: 24792335 PMCID: PMC4090351 SCOPUS ID: 2-s2.0-84901624214 05/06/2014       54 Citations
  • Hemophagocytic lymphohistiocytosis masquerading as progressive chronic lymphocytic leukemia. (Kilari D, Venci N, Friedberg J, Bennett JM) Leuk Res Rep 2013;2(1):4-6 PMID: 24371766 PMCID: PMC3850386 SCOPUS ID: 2-s2.0-84878370734 12/29/2013       5 Citations
  • An observational study of plasma vascular endothelial growth factors (VEGF) A and D expression in non-localized prostate cancer. (Verdoorn BP, Feng C, Ricke WA, Sahasrabudhe DM, Kilari D, Kohli M) J Mens Health 2012 Sep 01;9(3):182-189 PMID: 24416090 PMCID: PMC3886726 SCOPUS ID: 2-s2.0-84865162164 09/01/2012       1 Citation
  • An observational study of plasma vascular endothelial growth factors (vegf) a and d expression in non-localized prostate cancer (Verdoorn BP, Feng C, Ricke WA, Sahasrabudhe DM, Kilari D, Kohli M) Journal of Men's Health September 2012;9(3):182-189 SCOPUS ID: 2-s2.0-84865162164 09/01/2012       1 Citation
  • Management of cancer in the older adult. (Kilari D, Mohile SG) Clin Geriatr Med 2012 Feb;28(1):33-49 PMID: 22326034 SCOPUS ID: 2-s2.0-84856802493 02/14/2012       11 Citations
  • Inpatient management of sickle cell pain: a 'snapshot' of current practice. (Miller ST, Kim HY, Weiner D, Wager CG, Gallagher D, Styles L, Dampier CD, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN)) Am J Hematol 2012 Mar;87(3):333-6 PMID: 22231150 PMCID: PMC5047515 SCOPUS ID: 2-s2.0-84862777383 01/11/2012       29 Citations
  • Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial. (Peters-Lawrence MH, Bell MC, Hsu LL, Osunkwo I, Seaman P, Blackwood M, Guillaume E, Bellevue R, Krishnamurti L, Smith WR, Dampier CD, Minniti CP, Sickle Cell Disease Clinical Research Network (SCDCRN)) Contemp Clin Trials 2012 Mar;33(2):291-7 PMID: 22155024 PMCID: PMC3577351 SCOPUS ID: 2-s2.0-84856218422 12/14/2011       48 Citations
  • Last update: 10/26/2022